The treatment reduced the level of co-expression of VCAM and CD31 in tumor areas to that in normal brain tissues (score 1.8 vs 1, p = 0.06, right panels in Fig. 5e, f) which suggests normalized ECs. The gene discussed is PECAM1; the disease is neoplasm.